Antecka E - Search Results

1

Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.

Cools-Lartigue JJ, McCauley CS, Marshall JC, Di Cesare S, Gregoire F, Antecka E, Logan P, Burnier MN. Cools-Lartigue JJ, et al. Among authors: antecka e. Mol Vis. 2008 Jan 10;14:50-5. Mol Vis. 2008. PMID: 18246031 Free PMC article.

2

Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF.

Di Cesare S, Marshall JC, Logan P, Antecka E, Faingold D, Maloney SC, Burnier MN Jr. Di Cesare S, et al. Among authors: antecka e. J Carcinog. 2007 Jan 29;6:2. doi: 10.1186/1477-3163-6-2. J Carcinog. 2007. PMID: 17261188 Free PMC article.

3

The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma.

Marshall JC, Fernandes BF, Di Cesare S, Maloney SC, Logan PT, Antecka E, Burnier MN Jr. Marshall JC, et al. Among authors: antecka e. Carcinogenesis. 2007 Sep;28(9):2053-8. doi: 10.1093/carcin/bgm091. Epub 2007 Apr 13. Carcinogenesis. 2007. PMID: 17434930

4

Expression of nm23-H1 in uveal melanoma.

Bakalian S, Marshall JC, Faingold D, Logan P, Antecka E, Burnier MN Jr. Bakalian S, et al. Among authors: antecka e. Melanoma Res. 2007 Oct;17(5):284-90. doi: 10.1097/CMR.0b013e3282eeea5a. Melanoma Res. 2007. PMID: 17885583

5

[Detection of circulating malignant cells in patients with uveal melanoma].

Fernandes BF, Antecka E, dos Passos G, Burnier MN Jr. Fernandes BF, et al. Among authors: antecka e. Arq Bras Oftalmol. 2007 Jul-Aug;70(4):593-8. doi: 10.1590/s0004-27492007000400007. Arq Bras Oftalmol. 2007. PMID: 17906753 Free article. Portuguese.

6

In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines.

Di Cesare S, Marshall JC, Fernandes BF, Logan P, Antecka E, Filho VB, Burnier MN Jr. Di Cesare S, et al. Among authors: antecka e. Cancer Cell Int. 2007 Nov 14;7:17. doi: 10.1186/1475-2867-7-17. Cancer Cell Int. 2007. PMID: 18001467 Free PMC article.

7

Immune expression and inhibition of heat shock protein 90 in uveal melanoma.

Faingold D, Marshall JC, Antecka E, Di Cesare S, Odashiro AN, Bakalian S, Fernandes BF, Burnier MN Jr. Faingold D, et al. Among authors: antecka e. Clin Cancer Res. 2008 Feb 1;14(3):847-55. doi: 10.1158/1078-0432.CCR-07-0926. Clin Cancer Res. 2008. PMID: 18245548

8

SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.

Maloney SC, Marshall JC, Antecka E, Orellana ME, Fernandes BF, Martins C, Castiglione E, DI Cesare S, Logan P, Burnier MN Jr. Maloney SC, et al. Among authors: antecka e. Anticancer Res. 2009 Aug;29(8):3059-64. Anticancer Res. 2009. PMID: 19661316 Free article.

9

Lysyl oxidase expression and inhibition in uveal melanoma.

Abourbih DA, Di Cesare S, Orellana ME, Antecka E, Martins C, Petruccelli LA, Burnier MN Jr. Abourbih DA, et al. Among authors: antecka e. Melanoma Res. 2010 Apr;20(2):97-106. doi: 10.1097/CMR.0b013e328336edfe. Melanoma Res. 2010. PMID: 20179655

10

Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential.

Marshall JC, Caissie AL, Callejo SA, Antecka E, Burnier MN Jr. Marshall JC, et al. Among authors: antecka e. Pathobiology. 2004;71(5):241-5. doi: 10.1159/000080057. Pathobiology. 2004. PMID: 15459482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page